Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanxi Jincheng Hayes Pharmaceutical Co., Ltd. is a specialized Chinese pharmaceutical company focused on the development and large-scale manufacturing of anti-infective medications. Based in Jincheng, Shanxi Province, the company is a key subsidiary of the Jincheng Anthracite Mining Group and operates extensive GMP-certified facilities for oral solid dosage forms. Its product portfolio is anchored by high-quality generic antibiotics, most notably Cefdinir and Clarithromycin, which are used to treat a wide range of respiratory and systemic bacterial infections. The company maintains a strong presence in the domestic Chinese market and has established itself as a leading producer of cephalosporin and macrolide formulations. Jincheng Hayes integrates research, production, and sales to provide cost-effective therapeutic solutions within the infectious disease space.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jincheng Hayes Pharmaceutical.